Chimerism and a framework for clinical practice: A report from the Cellular Therapies Section Coordinating Committee ( CTSCC ) of Association for Advancement of Blood and Biotherapies ( AABB )

Key Points

• Chimerism plays a critical role in the effectiveness of cellular therapies, enhancing patient outcomes.
• Data derived from public resources like PubMed provides a foundation for the proposed framework.
• Observational analysis addresses the integration of chimerism into clinical practice for better results.
• This framework may enable advancements in biotherapies, though further validation is needed.

Abstract